Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

11:35 AM - 11:45 AM ET

208 - Bridging Radiotherapy Reduces Systemic Inflammation Prior to CAR T-Cell Therapy for B-Cell Lymphomas
Speaker: Imber, Brandon, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
11:45 AM - 11:55 AM ET

189 - Multicenter Patterns of Care Study - Quality of Radiotherapy for Dupuytren's Disease (DD) and Ledderhose (LD)
Speaker: Linke, Fränze - Strahlentherapie Ostalb, RadioOnkologieNetzwerk, Strahlentherapie Ostalb, Aalen, Deutschland, Aalen, Deutschland, Aalen
11:45 AM - 11:55 AM ET

196 - Comparative Prognostic Value of Disease-Specific Patient-Reported Outcomes in Prostate Cancer
Speaker: Lee, Minji, PhD - Mayo Clinic Rochester, Rochester, MN
11:45 AM - 11:55 AM ET

209 - a and ß Emitting Radiopharmaceutical Therapy (RPT) and Total Marrow and Lymphoid Irradiation (TMLI) Conditioning in Relapsed / Refractory (R/R) AML / ALL Undergoing Allogeneic Transplant (alloHCT)
Speaker: Wong, Jeffrey, MD, FASTRO - City of Hope National Medical Center, Duarte, CA
11:45 AM - 11:55 AM ET

Discussant
Speaker: Jethwa, Krishan, MD - Mayo, Rochester, MN
11:45 AM - 11:55 AM ET

Discussant
Speaker: Bakst, Richard, MD - Mount Sinai Health System and New York Proton Center, NEW YORK, NY
1:30 PM - 1:40 PM ET

1 - Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Sun, Guang-Yi - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
1:40 PM - 1:50 PM ET

2 - Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma (HCC) (NCT03186898)
Speaker: Hong, Theodore, MD - Massachusetts General Hospital, Boston, Massachusetts
1:50 PM - 2:00 PM ET

3 - SWOG S1827/MAVERICK: A Randomized Phase III Trial of Brain MRI Surveillance with and without Prophylactic Cranial Irradiation (PCI) for Small-Cell Lung Cancer (SCLC)
Speaker: Rusthoven, Chad, MD - University of Colorado School of Medicine, Aurora, COLORADO
2:00 PM - 2:10 PM ET

4 - Long-Term Impact of Low-Dose Radiotherapy on Disability and Arthroplasty in Knee Osteoarthritis: A 13-Year Randomized Trial
Speaker: Koneru, Nagendra (Bobby), MD, FASTRO - FHN Memorial Hospital, Freeport, IL
2:10 PM - 2:20 PM ET

5 - Low-Dose Radiotherapy for Knee Osteoarthritis: Sustained Clinical Benefit and MRI-Confirmed Structural Outcomes from a Randomized Trial
Speaker: Koneru, Nagendra (Bobby), MD, FASTRO - FHN Memorial Hospital, Freeport, IL
3:00 PM - 3:10 PM ET

210 - Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Speaker: Ahmed, Kamran, MD - H. Lee Moffitt Cancer Center, Tampa, FL